Aarti Surfactants Ltd
NSE: AARTISURF BSE: 543210FMCG
Incorporated in 2018, Aarti Surfactants Ltd is in the business of Home and personal care ingredients[1]
₹383
52W: ₹316 — ₹653
PE 25.6 · Book ₹292 · +31% vs bookMarket Cap₹324 Cr
Stock P/E25.6Price to Earnings
ROCE8.58%Return on Capital
ROE5.27%Return on Equity
Div. Yield0.25%Face Value ₹10
Strengths
- +Company's working capital requirements have reduced from 32.3 days to 21.5 days
Weaknesses
- −Company has a low return on equity of 7.11% over last 3 years.
- −Dividend payout has been low at 4.11% of profits over last 3 years
Shareholding Pattern
Promoters49.88%
FIIs0.14%
DIIs0%
Public49.98%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 49.81% | 49.92%▲0.1 | 49.92% | 49.92% | 49.92% | 49.92% | 49.88%▼0.0 | 49.88% |
| FIIs | 0.04% | 0.06%▲0.0 | 0%▼0.1 | 0.14%▲0.1 | 0%▼0.1 | 0% | 0% | 0.14%▲0.1 |
| DIIs | 0% | 1.06%▲1.1 | 0.8%▼0.3 | 0.8% | 0.8% | 0.8% | 0.3%▼0.5 | 0%▼0.3 |
| Public | 50.14% | 48.95%▼1.2 | 49.26%▲0.3 | 49.13%▼0.1 | 49.27%▲0.1 | 49.26%▼0.0 | 49.8%▲0.5 | 49.98%▲0.2 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 138.75 | 158.55 | 143.41 | 150.84 | 162.78 | 202.05 | 215.9 | 179.17 | 207.79 | 256.28 |
| Expenses | 122.02 | 143.34 | 133.74 | 147.07 | 153.84 | 182.3 | 204.21 | 169.81 | 195.08 | 243.05 |
| Operating Profit | 16.73 | 15.21 | 9.67 | 3.77 | 8.94 | 19.75 | 11.69 | 9.36 | 12.71 | 13.23 |
| OPM % | 12.06% | 9.59% | 6.74% | 2.5% | 5.49% | 9.77% | 5.41% | 5.22% | 6.12% | 5.16% |
| Net Profit | 6.68 | 5.59 | 2.33 | 1.92 | 0.91 | 9.84 | 3.06 | 1.63 | 3.73 | 4.26 |
| EPS ₹ | 7.86 | 6.61 | 2.75 | 2.27 | 1.08 | 11.63 | 3.62 | 1.93 | 4.41 | 5.03 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹859Cr, up 30.3% YoY. OPM at 5%.
Debt Position
Borrowings at ₹104Cr. Debt-to-equity ratio: 0.44x. Healthy balance sheet.
Capex Cycle
CWIP at ₹40Cr (20% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0% (+0.00pp change). FIIs: 0.14% (+0.10pp change). Promoters hold 49.88%.
Margin & Efficiency
ROCE improving from 0% (Mar 2019) to 9% (Mar 2026). Working capital days: 22.
Valuation
PE 25.6x with 8.58% ROCE. Price is 31% above book value of ₹292. Dividend yield: 0.25%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 11 May
- Re-Appointment Of Cost Auditor & Internal Auditor For FY 2026-2027 9 May - Board approved FY26 audited results, recommended Re.1 dividend, and reappointed auditors on May 9, 2026.
- Corporate Action-Board to consider Dividend 9 May - Board approved FY26 audited results, recommended Re.1 dividend, and reappointed cost and internal auditors.
- Financial Results For The Quarter And Year Ended March 31, 2026 9 May - Board approved FY26 audited results, recommended Re.1 dividend, and reappointed auditors on May 9, 2026.
- Board Meeting Outcome for Outcome Of Board Meeting 9 May - Board approved FY26 audited results, recommended Re.1 dividend, reappointed auditors, and changed finance committee.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse